This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Riverside: The Acquisition of Euromed - Teaching Note
-
Reference: FT-119-E
-
Year: 2015
-
Number of pages: 17
-
Geographic Setting: España
-
Publication Date: Dec 17, 2020
-
Source: IESE (España)
-
Type of Document: Teaching Note
Description
In December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.